Bergen Gynecologic Cancer Research Group

Our research is focused on molecular alterations in gynaecologic cancer, to define potential targets for new therapies and develop reliable biomarkers for individualised therapy. The goal is to perform a comprehensive molecular profiling of primary- and metastatic lesions from cervical, endometrial- and ovarian carcinomas in order to improve trials with molecularly targeted therapy. This project represents clinical research with a strong focus on translational aspects. The study is part of a collaborative platform with Harvard, Dana Farber Cancer Institute, and MIT working towards the global characterisation of molecular alterations in metastatic gynaecologic cancer.  Click here for more information.